AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 41 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $29,000 | -12.1% | 12,153 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | +26.9% | 12,153 | 0.0% | 0.00% | – |
| Q4 2018 | $26,000 | -73.5% | 12,153 | -63.6% | 0.00% | – |
| Q3 2018 | $98,000 | +16.7% | 33,401 | +4.9% | 0.00% | – |
| Q2 2018 | $84,000 | -77.0% | 31,838 | +22.5% | 0.00% | – |
| Q1 2018 | $366,000 | +46.4% | 25,984 | +22.5% | 0.00% | – |
| Q4 2017 | $250,000 | +29.5% | 21,210 | +55.4% | 0.00% | – |
| Q3 2017 | $193,000 | +17.7% | 13,653 | +16.7% | 0.00% | – |
| Q2 2017 | $164,000 | -15.9% | 11,700 | 0.0% | 0.00% | – |
| Q1 2017 | $195,000 | +3.7% | 11,700 | +2.6% | 0.00% | – |
| Q4 2016 | $188,000 | +22.9% | 11,400 | 0.0% | 0.00% | – |
| Q3 2016 | $153,000 | +96.2% | 11,400 | -4.2% | 0.00% | – |
| Q2 2016 | $78,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |